DEVELOPMENT OF A STABLE BIOPHARMACEUTICAL FORMULATION FOR A MONOCLONAL ANTIBODY aHER2

• MsC. Yaiko Saddan Hernández Terrero

• English

• aher2
• biopharmaceutical
• characterization
• formulation
• monoclonal antibody
• screening

The development of pharmaceutical formulations of monoclonal antibodies is of vital importance to achieve effective and safe drugs. Hence, many research groups have focused on using different screening strategies to optimize the formulation for each antibody under study. Within the excipients used to carry out the screening of formulation are carbohydrates, salts, surfactants and amino acids. In our work we focused specifically on a monoclonal antibody aHer2 for the treatment of breast cancer ty...